Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-8300
Fax+1 214-645-9225
Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shaida Khan is a neurologist in Dallas, TX. She received her medical degree from Texas College of Osteopathic Medicine and has been in practice 8 years. She specializes in neuromuscular medicine.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2016 - 2019
- University of Texas Southwestern Medical CenterResidency, Neurology, 2012 - 2016
- Texas College of Osteopathic MedicineClass of 2012
Certifications & Licensure
- TX State License 2016 - 2027
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- UTSW Wellstone MDCRC Training Grant NIH, 2016-2018
- Fellow Scholarship to the Annual Meeting American Academy of Neurology, 2017
- Fred Baskin Young Investigator Award UT Southwestern Medical Center, 2017
- Join now to see all
Clinical Trials
- A Study of RVT-1401 in Myasthenia Gravis (MG) Patients Start of enrollment: 2019 May 21
- Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis Start of enrollment: 2019 Sep 17
- Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis Start of enrollment: 2019 Dec 23
Publications & Presentations
PubMed
- 2 citationsEvaluation of the impact of neurology electronic consults (e-consults): Experiences of a neurology resident clinic in a safety-net hospital.Lauren Tardo, Siegfried Hirczy, Kyle Blackburn, Maria Mejia, Amber Salter
Journal of Telemedicine and Telecare. 2025-10-01 - Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study.Miriam Freimer, Urvi Desai, Raghav Govindarajan, Min K Kang, Shaida Khan
Therapeutic Advances in Neurological Disorders. 2025-01-01 - 1 citationsDesign and Implementation of a Brief, Self-Directed Course on Immunotherapy Best Practices for Neurology Trainees.Kyle M Blackburn, Peter V Sguigna, Lauren Tardo, Shaida Khan, Steven Vernino
Journal of Medical Education and Curricular Development. 2024-08-09
Books/Book Chapters
Abstracts/Posters
- Cardiac Atrophy: A Novel Mechanism for Duchenne Muscular Dystrophy (DMD)-Associated CardiomyopathyShaida Khan, Daniel Cheeran, Sonia Garg, Justin Grodin, Robert Morlend, Faris Araj, Alpesh Amin, Jennifer Thibodeau, Mark Drazner and Pradeep Mammen, Journal of the American College of Cardiology, 3/2017
Grant Support
- Paul D. Wellstone Muscular Dystrophy Cooperative Research - Wellstone trainee clinical fellowship awardNational Institutes of Health2016–2018
Professional Memberships
- Member
- Member
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: